Authors : Jagriti Rana, Santosh Kumar, Mimansaa Agasti
DOI : 10.18231/j.ijooo.2019.016
Volume : 5
Issue : 2
Year : 2019
Page No : 61-64
Introduction: A chalazion is a chronic, sterile lipo-granulomatous inflammatory lesion caused due to the blocked sebaceous secretion from the Meibomian and other sebaceous glands. Its painless and harmless, until it becomes an enlarged upper lid chalazion producing mass effect on the cornea leading to blurred vision and astigmatism.
Aim: The aim of our study was to inject 0.1 ml of triamcinolone intralesionally and compare the results in both paediatric and adult age group. We assessed how much time was required for the regression of the lesion and how many patients were in the need for re-injection. We also assessed the need for incision and curettage in such patients.
Materials and Methods: Sixty-seven patients were included in the study, out of which 23 were children and 44 were adults. 0.1 ml of triamcinolone (40 mg/dl) was injected intralesionally using a 26 gauge needle. The eyelid was everted and the injection was given transconjunctivally into the centre of the lesion. The eye was not patched.
Results: Most lesions resolved within 1 week, the maximum time being 3 weeks in both study populations. Repeat injection was needed in only 1 case in paediatric age group and 15 cases in adult age group. None of our patients developed any adverse effects.
Conclusion: Usually, chalazion is a self-limiting disease and intralesional injection of triamcinolone is a very effective modality for treatment. It can be done under topical anaesthesia, causing much less bleeding and the risk of scarring is almost not there. It is a very quick procedure, performed in a sterilized out-patient setting, requires no special instruments and is very less painful. Its safely tolerated by both children and adults and should be considered as a preferable procedure over incision and curettage.
Keywords: Intralesional, Chalazion.